EDGAR Filing Documents for 0001193125-15-272844

Form CORRESP - Correspondence:

SEC Accession No. 0001193125-15-272844

Filing Date

2015-07-31

Accepted

2015-07-31 15:20:52

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	19972
2	GRAPHIC	g912889gp00002.jpg	GRAPHIC	2958
	Complete submission text file	0001193125-15-272844.txt		25040

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110

Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0

Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations